Épisodes

  • Why Branding Is Becoming Cannabis’s Biggest Advantage | TDR Cannabis in 5
    Jan 14 2026
    Why is branding becoming one of the most important separating factors in the cannabis industry as we move deeper into 2026?This episode of TDR Cannabis in Five takes a closer look at how the cannabis market is shifting from survival mode into a more mature, consumer-driven phase — and why brand identity is starting to matter as much as cultivation, pricing, or retail footprint.For years, cannabis companies were focused on staying afloat amid price compression, limited access to capital, and regulatory uncertainty. But as the industry inches closer to potential uplisting, banking reform, and broader institutional participation, the competitive landscape is changing. Companies are no longer being judged solely on scale or cost efficiency. Increasingly, they’re being evaluated on whether they can build durable brands that consumers recognize, trust, and return to.This episode uses cannabis stock MariMed (OTCQX: MRMD) as a case study, focusing on its edible brand Betty’s Eddies. Rather than chasing rapid expansion, MariMed invested early in brand development — from product formulation and packaging to positioning that aligns more closely with wellness and consumer packaged goods than novelty cannabis products.The discussion also looks at how Betty’s Eddies has performed in highly competitive markets like Massachusetts and Illinois, including its ability to regain momentum after a multi-year absence from shelves. That kind of portability — where a brand can exit a market and successfully re-enter later — highlights the long-term value of brand equity in cannabis.As the industry continues to mature, this episode frames branding not as marketing hype, but as infrastructure — something that can support pricing power, repeat purchases, and long-term resilience as competition intensifies.#CannabisBranding #CannabisIndustry #MariMed #MRMD #BettysEddies #CannabisCPG #CannabisEdibles #CannabisInvesting #CannabisMarkets #CannabisStocksWant to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    7 min
  • Which States Are Most Likely to Legalize Cannabis in 2026? | TDR Cannabis in 5
    Jan 13 2026
    Which states are actually positioned to legalize marijuana in 2026 — and which ones just keep showing up in headlines without real momentum?That’s the question this episode of TDR Cannabis in Five, presented by Flowhub, takes on using new reporting and data highlighted by Marijuana Moment. With federal cannabis rescheduling hanging in the balance, state-level reform is back in focus — and in some cases, it may matter more than ever.As of early 2026, nearly half of U.S. states already allow adult-use cannabis, and most permit medical access. But reform hasn’t stalled. Instead, it’s shifted into a more targeted phase, where a handful of states show real, measurable movement — through ballot initiatives, legislative action, or political alignment — while others remain stuck.This episode breaks down the states most likely to see progress next year, including Florida, where a 2026 adult-use ballot initiative is moving through legal review, and Pennsylvania, where lawmakers continue debating legalization as a revenue and regulatory issue. It also looks at states like New Hampshire and Hawaii, where legislative momentum has quietly been building, and Virginia, where adult possession is legal but retail sales still haven’t launched.Medical cannabis is part of the story too. States like Idaho and Kansas — long resistant to reform — are seeing renewed efforts to establish medical programs, while North Carolina and South Carolina continue to study or debate next steps.Rather than predicting outcomes, this episode focuses on where the policy pressure points actually are — and what those state-level moves say about how cannabis reform is unfolding in a post-rescheduling environment.#CannabisLegalization #CannabisPolicy #MarijuanaMoment #CannabisReform #StateLegalization #Cannabis2026 #CannabisNews #CannabisIndustry #MedicalCannabis #AdultUseCannabisWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    9 min
  • GOP Pushes Back on Rescheduling Fears | TDR Cannabis in 5
    Jan 13 2026
    So… is cannabis rescheduling actually happening, or are we stuck watching another slow-motion government process?That’s the question a lot of people are asking right now — especially after the DEA confirmed the rescheduling appeal process is still technically pending, even after President Trump’s executive order. On the surface, that sounds like a delay. But once you slow things down and look at how this process actually works, the story gets a lot clearer.In this episode of TDR Cannabis in Five presented by Flowhub, Shadd Dales breaks down where things really stand with federal cannabis rescheduling — and why “pending” doesn’t mean “dead.” A Republican lawmaker closely involved in cannabis policy, Rep. Dave Joyce of Ohio, says concerns about the DOJ dragging its feet are overblown. According to Joyce, Trump was very clear in directing federal agencies to move cannabis out of Schedule I and into Schedule III.Here’s the key point: executive orders don’t flip a switch overnight. They start a process — one that involves scientific review, administrative steps, and legal safeguards. That’s exactly where we are now.This episode walks through what Schedule III would actually change — and what it wouldn’t. Easier research access? Yes. Potential tax relief for operators? Possibly. Instant legalization or federal free-for-all? Not even close.We also talk about why lawsuits are expected, why they face an uphill battle, and why alignment between the White House, HHS, and the DEA matters more than daily headlines.Bottom line: this isn’t a story about whether rescheduling happens. It’s about timing, execution, and making sure it sticks.And that’s where things get interesting.#CannabisRescheduling #ScheduleIII #CannabisPolicy #FederalCannabis #TDRCannabisInFive #CannabisReform #CannabisIndustry #DEA #DOJ #FlowhubWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    7 min
  • What Washington is Saying on Cannabis Rescheduling
    Jan 12 2026
    Is federal cannabis rescheduling actually moving forward — or are we still waiting on Washington to show its hand?We’ll start with the latest comments from a GOP congressman pushing back on concerns that cannabis rescheduling is stalled, saying President Trump made it clear the Department of Justice must act. That raises an important question: if the directive is clear, what happens next — and what are industry participants watching for while the DEA process remains pending?We’ll also discuss continued congressional resistance to allowing Washington, D.C. to move forward with regulated cannabis sales, highlighting the ongoing disconnect between federal oversight and local voter intent.On the corporate side, Village Farms International (NASDAQ: VFF) announced new product innovation in the Dutch market. Plus, Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, joins us for our weekly Insider’s Edge segment. Michael will share the latest from Washington, including where things stand on cannabis scheduling and whether there’s any clearer visibility yet on Attorney General Pam Bondi formally signing off.All of that and more — today at 4 PM Eastern on Trade to Black presented by Flowhub.#TradeToBlack #CannabisPolicy #CannabisRescheduling#FederalCannabis #CannabisInvesting #Flowhub #CannabisIndustry#WashingtonDC #GlobalCannabis #CannabisNewsWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • The $4 Billion Problem Facing U.S. Cannabi... • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    53 min
  • The $4 Billion Problem Facing U.S. Cannabis | TDR Cannabis in 5
    Jan 12 2026
    What happens after cannabis rescheduling — once the headlines fade and operators are left to actually scale?In this episode of TDR Cannabis in Five, host Shadd Dales kicks off a new series focused on the less talked-about side of a post-rescheduling cannabis industry: infrastructure, cash flow, and execution. Because if rescheduling does move forward, the biggest challenge won’t be access — it’ll be discipline.The U.S. cannabis industry generates roughly $30 billion annually, yet an estimated $4 billion of that is tied up in unpaid invoices. That’s more than 10% of all transactions sitting in delinquent accounts receivable — a structural problem that affects MSOs and private operators alike. In a market where suppliers can’t easily cut off non-paying buyers, unpaid bills quietly erode margins, slow growth, and strain balance sheets.This episode breaks down why receivables have become one of the industry’s biggest hidden risks — and why fixing them is critical if cannabis wants to mature beyond survival mode.The discussion also highlights how some operators and service providers are adapting to this reality. Using examples from the supply chain, the episode looks at how financing tools tied directly to real sales — rather than speculative growth — can help companies scale responsibly without stretching their balance sheets.The broader takeaway is simple: rescheduling alone won’t fix cannabis. The next phase of the industry will reward companies that understand underwriting, enforce payment discipline, and build systems that support sustainable growth.This series will continue to unpack what real scale looks like — market by market, balance sheet by balance sheet — in a cannabis industry that’s finally being forced to grow up.#CannabisIndustry #CannabisBusiness #CannabisFinance #CannabisRescheduling #TDRCannabisInFive #CannabisOperators #CannabisSupplyChain #CannabisInvesting #CannabisInfrastructureWant too see last week's recap? • Cannabis Enters 2026 With a New Tone | TTB... Want to see more Cannabis Reform videos? • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... • Former AG Bill Barr Enters Cannabis Resche... • Inside the Politics of Rescheduling | TDR ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    7 min
  • CA Skip navigation Search Create 5 Avatar image Cannabis Enters 2026 With a New Tone | TTB Weekly Recap
    Jan 11 2026
    What does the cannabis industry actually look like heading into 2026 — once the noise fades and the data sets in?In this first TDR Weekly Recap of 2026 presented by Flowhub, host Shadd Dales steps back to frame where the cannabis sector truly stands after a turbulent but stabilizing 2025. This isn’t about chasing short-term stock moves. It’s about understanding how policy, capital discipline, and execution quietly reshaped the industry — and why that matters now.The episode breaks down why 2025 became less about survival and more about fundamentals. Across Canada and the U.S., companies moved away from expansion-at-all-costs strategies and refocused on profitability, balance sheets, and core markets. Canadian licensed producers leaned into operational discipline and international medical exports, while U.S. operators navigated a policy-heavy year that finally delivered forward momentum.A major focus this week is federal cannabis rescheduling. President Trump’s executive directive moved rescheduling from rumor to timeline. With Attorney General Pam Bondi now responsible for final execution, the conversation has shifted from “if” to “when” — a meaningful change for operators and investors alike.The recap also covers renewed but disciplined M&A activity, diverging state-level policy paths, fresh medical cannabis data out of the UK, and notable company updates from Tilray Brands (NASDAQ: TLRY), SNDL (NASDAQ: SNDL), and Curaleaf (TSX: CURA).#CannabisIndustry #CannabisNews #TDRWeeklyRecap #Cannabis2026 #CannabisPolicy #CannabisRescheduling #CannabisInvesting #CannabisMarkets #CannabisBusiness #FlowhubWant to see more Cannabis Reform videos? • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... • Former AG Bill Barr Enters Cannabis Resche... • Inside the Politics of Rescheduling | TDR ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    10 min
  • Florida’s Medical Cannabis Sales Decline in December | TDR Cannabis in 5
    Jan 10 2026
    So what does it actually mean when Florida’s medical cannabis market is down for a month — and does it change the bigger picture?Today on TDR Cannabis in Five, presented by Flowhub, host Shadd Dales takes a closer look at Florida’s medical cannabis market and separates the headline from the reality. Florida remains the largest medical-only cannabis market in the United States by patient count, retail footprint, and total annual sales. That hasn’t changed.At the same time, recent data shows Florida’s medical market declined slightly last month compared to the same period a year ago. That detail matters — but it needs context.This episode breaks down why short-term softness doesn’t equal long-term weakness, especially in a mature medical market. Florida has reached a phase where growth is incremental, competition is intense, and pricing dynamics play a larger role in monthly performance. Unit sales remain steady, dispensary count continues to rise, and patient participation is still expanding — just at a slower pace than earlier years.In other words, Florida is behaving like what it is: a large, established medical cannabis market.Without an adult-use channel to expand the consumer base, month-to-month fluctuations are normal. That doesn’t change Florida’s importance to multi-state operators, nor does it diminish its role in U.S. cannabis strategy going forward.The takeaway is simple and balanced: Florida is still the largest medical cannabis market in the country — and last month, sales were modestly lower. Both things can be true at the same time.#FloridaCannabis #MedicalCannabis #CannabisMarket #TDRCannabisInFive #Flowhub #CannabisIndustry #CannabisInvesting #FloridaMedicalMarijuana #CannabisData #CannabisPolicyWant to see more Cannabis Reform videos? • Inside the Final Steps of Cannabis Resched... • Supreme Court Takes Cannabis Gun Case | TD... • Former AG Bill Barr Enters Cannabis Resche... • Inside the Politics of Rescheduling | TDR ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    6 min
  • Inside the Final Steps of Cannabis Rescheduling | TDR Cannabis in 5
    Jan 10 2026
    So what’s really going on with cannabis rescheduling — and why does it still feel unfinished?Today on TDR Cannabis in Five, presented by Flowhub, host Shadd Dales revisits the rescheduling story with some much-needed context. Yes, the DEA has confirmed that the appeal process is technically still pending — even after President Trump’s executive order. But that headline alone misses the bigger picture.This episode breaks down what “pending” actually means inside federal administrative law, and why it doesn’t signal resistance or reversal. The key lies in the Department of Health and Human Services report — the scientific foundation that reshaped the entire conversation around cannabis scheduling. That report reviewed decades of medical use, patient outcomes, and real-world data, and clearly concluded that cannabis no longer belongs in Schedule I.With HHS setting the scientific framework, the DEA isn’t starting from scratch. It’s completing the final procedural steps required to make rescheduling legally durable — especially in a landscape where lawsuits are expected. That alignment between the White House, HHS, and the DEA matters more than speed.This episode focuses on separating headlines from process, emotion from evidence, and noise from signal. Because rescheduling was never going to happen overnight — it was always going to move through formal channels designed to make the outcome stick.#CannabisRescheduling #CannabisPolicy #DEA #HHSReport #CannabisIndustry #CannabisInvesting #FederalCannabis #TDRCannabisInFive #Flowhub #CannabisNewsWant to see more Cannabis Reform videos? • Supreme Court Takes Cannabis Gun Case | TD... • Former AG Bill Barr Enters Cannabis Resche... • Inside the Politics of Rescheduling | TDR ... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
    Afficher plus Afficher moins
    7 min